";s:4:"text";s:4709:" Caution should be used when initiating treatment with rasagiline in patients with mild hepatic impairment.
A similar pattern of excessive daily sleepiness has been reported post-marketing with rasagiline.Cases of patients, treated with rasagiline and other dopaminergic medicinal products, falling asleep while engaged in activities of daily living have been reported. Use WebMD’s Drug Interaction Checker tool to find and identify potentially harmful and unsafe combinations of prescription medications by entering two or more drugs in question. At least 14 days must elapse between discontinuation of rasagiline and initiation of treatment with MAO inhibitors or pethidine.The concomitant use of rasagiline and fluoxetine or fluvoxamine should be avoided (see section 4.5). Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records.
Your condition will not improve any faster, and your risk of side effects will increase.Keep taking this medication even if you feel well. You may report side effects to Health Canada at 1-866-234-2345.This drug may make you dizzy or drowsy. Do not use a household spoon because you may not get the correct dose.For powder packets, empty the entire contents of the packet onto the Improper use of this medication (abuse) may result in serious harm (such as This is not a complete list of possible side effects. In the post-marketing period, cases of elevated blood pressure, including rare serious cases of hypertensive crisis associated with ingestion of unknown amounts of tyramine-rich foods, have been reported in patients taking rasagiline. It is usually used along with rest and physical therapy. Take your next dose at the regular time. Adrenaline/epinephrine . Additional cases of malignant melanoma were reported during post-marketing period. The dose of this medicine will be different for different patients. The metabolism of rasagiline proceeds through two main pathways: N-dealkylation and/or hydroxylation to yield: 1-Aminoindan, 3-hydroxy-N-propargyl-1 aminoindan and 3-hydroxy-1-aminoindan. Description and Brand Names; Before Using; Proper Use; Precautions; Side Effects; Products and services. Adverse reactions were mild or moderate and not related to rasagiline treatment. Identify these serious oxycodone oral (Dazidox Oral, Endocodone Oral, ETH-Oxydose Oral, Oxaydo Oral, Oxecta Oral) drug interactions with the RxList drug interaction checker tool. Sections. Limit your time in the sun.